We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

21 hedge funds and large institutions have $5.2M invested in Bristol-Myers Squibb Rights in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $4.17M → $5.2M (+$1.03M)

17% more funds holding

Funds holding: 18 → 21 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0.02% → 0.03% (+0%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.98K
2
TSS
Two Sigma Securities
New York
+$626
3
TPA
Trivium Point Advisory
Connecticut
+$397
4
UBS Group
UBS Group
Switzerland
+$144

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$349
2
Citadel Advisors
Citadel Advisors
Florida
-$13
3
IAIM
International Assets Investment Management
Florida
-$7
4
Morgan Stanley
Morgan Stanley
New York
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
FourWorld Capital Management
New York
$5.17M – – –
TCA
2
Transcend Capital Advisors
New Jersey
$5.65K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$5.44K -$349 -8,800 -7%
DC
4
Davenport & Co
Virginia
$4.03K – – –
Bank of America
5
Bank of America
North Carolina
$2.48K +$1.98K +49,800 +2,709%
Citadel Advisors
6
Citadel Advisors
Florida
$1.8K -$13 -332 -0.9%
Fifth Third Bancorp
7
Fifth Third Bancorp
Ohio
$960 – – –
TSS
8
Two Sigma Securities
New York
$757 +$626 +15,771 New
PAG
9
Private Advisor Group
New Jersey
$720 – – –
WGC
10
Watts Gwilliam & Co
Arizona
$700 +$794 +20,000 New
TPA
11
Trivium Point Advisory
Connecticut
$600 +$397 +10,000 New
UBS Group
12
UBS Group
Switzerland
$176 +$144 +3,636 +11,729%
IAIM
13
International Assets Investment Management
Florida
$175 -$7 -167 -95%
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$17 – – –
RIL
15
Rothschild Investment LLC
Illinois
$8 – – –
Morgan Stanley
16
Morgan Stanley
New York
$6 -$2 -45 -27%
OC
17
Oakworth Capital
Alabama
$6 – – –
AEPWM
18
Atlantic Edge Private Wealth Management
Florida
$1 – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$1 – – –
Wells Fargo
20
Wells Fargo
California
$1 – – –

CELG.RT Hedge Fund Activity: Q3 2024 in Review

21 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q3 2024, worth a combined $5.2M — up 25% from $4.17M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CELG.RT positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Bank of America, adding an estimated $1.98K. The largest seller was Susquehanna International Group, cutting an estimated $349.

  • 21 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q3 2024, up from 18 in Q2 2024.
  • Funds reported $5.2M of Bristol-Myers Squibb Rights stock for Q3 2024, up 25% quarter-over-quarter.
  • 3 funds opened new Bristol-Myers Squibb Rights positions in Q3 2024 and 0 closed out, a net change of +3 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q3 2024 was Bank of America, an estimated $1.98K added.
  • The largest Bristol-Myers Squibb Rights seller in Q3 2024 was Susquehanna International Group, an estimated $349 sold.

Based on aggregated 13F filings for Q3 2024.